Publications:

---

Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers.

Frontiers In Molecular Biosciences

Zheng, Yang Y; Zou, Jiayu J; Sun, Chen C; Peng, Fu F; Peng, Cheng C

Publication Date: 2023

Variant appearance in text: HER2: S310F

PubMed Link: 37251081

Variant Present in the following documents:

• Main text
• fmolb-10-1165781.pdf

View BVdb publication page

---

Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.

Scientific Reports

Hsu, Che-Yuan CY; Yanagi, Teruki T; Maeda, Takuya T; Nishihara, Hiroshi H; Miyamoto, Kodai K; Kitamura, Shinya S; Tokuchi, Keiko K; Ujiie, Hideyuki H

Publication Date: 2023-05-27

Variant appearance in text: ERBB2: S310F

PubMed Link: 37244956

Variant Present in the following documents:

• 41598_2023_Article_35811.pdf

View BVdb publication page

---

The Role of HER2 Status in the Biliary Tract Cancers.

Cancers

Ayasun, Ruveyda R; Ozer, Muhammet M; Sahin, Ilyas I

Publication Date: 2023-05-05

Variant appearance in text: HER2: S310F

PubMed Link: 37174094

Variant Present in the following documents:

• Main text
• cancers-15-02628.pdf

View BVdb publication page

---

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer.

Frontiers In Oncology

Han, Yanjie Y; Xiong, Yuanyuan Y; Lu, Tao T; Chen, Rongrong R; Liu, Yuan Y; Tang, Hui H; Geng, Ruixuan R; Wang, Yingyi Y

Publication Date: 2023

Variant appearance in text: HER2: S310F

PubMed Link: 37077822

Variant Present in the following documents:

• Main text
• fonc-13-1121708.pdf

View BVdb publication page

---

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications

Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA

Publication Date: 2023-04-03

Variant appearance in text: ERBB2: S310F

PubMed Link: 37012232

Variant Present in the following documents:

• 41467_2023_37547_MOESM10_ESM.xlsx, sheet 4
• 41467_2023_37547_MOESM10_ESM.xlsx, sheet 3
• 41467_2023_37547_MOESM10_ESM.xlsx, sheet 2
• 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
• 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2

View BVdb publication page

---

Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers.

Bmc Cancer

Xie, Jianjiang J; Yao, Weishen W; Chen, Lingxiu L; Zhu, Wenjun W; Liu, Qiang Q; Geng, Geng G; Fang, Jing J; Zhao, Yang Y; Xiao, Li L; Huang, Zhenhua Z; Zhao, Jing J

Publication Date: 2023-03-31

Variant appearance in text: ERBB2: Ser310Phe

PubMed Link: 37004022

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications.

Cancer Medicine

Zhao, Zhiming Z; Li, Xiaomo X; Wang, Fei F; Xu, Yong Y; Liu, Si S; Han, Quanli Q; Yang, Zhiying Z; Huang, Weiwei W; Yin, Zhuzeng Z; Liu, Qu Q; Tan, Haidong H; Ma, Tonghui T; Si, Shuang S; Huang, Jia J; Yuan, Hongling H; Li, Wei W; Liu, Rong R

Publication Date: 2023-03-31

Variant appearance in text: HER2: S310F

PubMed Link: 36999792

Variant Present in the following documents:

• Main text
• CAM4-12-11672.pdf

View BVdb publication page

---

Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes.

Nature Communications

Li, Lingling L; Jiang, Dongxian D; Liu, Hui H; Guo, Chunmei C; Zhao, Rui R; Zhang, Qiao Q; Xu, Chen C; Qin, Zhaoyu Z; Feng, Jinwen J; Liu, Yang Y; Wang, Haixing H; Chen, Weijie W; Zhang, Xue X; Li, Bin B; Bai, Lin L; Tian, Sha S; Tan, Subei S; Yu, Zixiang Z; Chen, Lingli L; Huang, Jie J; Zhao, Jian-Yuan JY; Hou, Yingyong Y; Ding, Chen C

Publication Date: 2023-03-29

Variant appearance in text: ERBB2: S310F; rs1057519816

PubMed Link: 36991000

Variant Present in the following documents:

• 41467_2023_37221_MOESM5_ESM.xlsx, sheet 3

View BVdb publication page

---

Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.

Cancer Research Communications

Frank, Malene S MS; Andersen, Christina S A CSA; Ahlborn, Lise B LB; Pallisgaard, Niels N; Bodtger, Uffe U; Gehl, Julie J

Publication Date: 2022-10

Variant appearance in text: ERBB2: 929C>T; S310F

PubMed Link: 36969747

Variant Present in the following documents:

• crc-22-0258-s08.xlsx, sheet 1

View BVdb publication page

---

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

Npj Precision Oncology

Ritch, Elie J EJ; Herberts, Cameron C; Warner, Evan W EW; Ng, Sarah W S SWS; Kwan, Edmond M EM; Bacon, Jack V W JVW; Bernales, Cecily Q CQ; Schönlau, Elena E; Fonseca, Nicolette M NM; Giri, Veda N VN; Maurice-Dror, Corinne C; Vandekerkhove, Gillian G; Jones, Steven J M SJM; Chi, Kim N KN; Wyatt, Alexander W AW

Publication Date: 2023-03-13

Variant appearance in text: ERBB2: S310F

PubMed Link: 36914848

Variant Present in the following documents:

• 41698_2023_366_MOESM2_ESM.xlsx, sheet 4

View BVdb publication page

---

Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC.

Frontiers In Oncology

He, Ping P; Liu, Jie J; Xu, Qingyuan Q; Ma, Huaijun H; Niu, Beifang B; Huang, Gang G; Wu, Wei W

Publication Date: 2023

Variant appearance in text: ERBB2: 929C>T; S310F; rs1057519816

PubMed Link: 36910641

Variant Present in the following documents:

• DataSheet_1.xlsx, sheet 8

View BVdb publication page

---

HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study.

Cancer Immunology, Immunotherapy : Cii

Chen, Meiting M; Yao, Kai K; Cao, Manming M; Liu, Hao H; Xue, Cong C; Qin, Tao T; Meng, Lingru L; Zheng, Zhousan Z; Qin, Zike Z; Zhou, Fangjian F; Liu, Zhuowei Z; Shi, Yanxia Y; An, Xin X

Publication Date: 2023-03-10

Variant appearance in text: HER2: S310F

PubMed Link: 36897337

Variant Present in the following documents:

• Main text
• 262_2023_Article_3419.pdf

View BVdb publication page

---

Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab: A case report.

World Journal Of Clinical Cases

Yang, Rui R; Chen, Jun-Xing JX; Luo, Shu-Hang SH; Chen, Ting-Ting TT; Chen, Ling-Wu LW; Huang, Bin B

Publication Date: 2023-02-16

Variant appearance in text: ERBB2: S310F

PubMed Link: 36874416

Variant Present in the following documents:

• WJCC-11-1165.pdf

View BVdb publication page

---

Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery

Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI

Publication Date: 2023-03-02

Variant appearance in text: ERBB2: 929C>T; Ser310Phe; rs1057519816

PubMed Link: 36862804

Variant Present in the following documents:

• cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 10
• cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6

View BVdb publication page

---

Pan-cancer clinical impact of latent drivers from double mutations.

Communications Biology

Yavuz, Bengi Ruken BR; Tsai, Chung-Jung CJ; Nussinov, Ruth R; Tuncbag, Nurcan N

Publication Date: 2023-02-20

Variant appearance in text: ERBB2: S310F

PubMed Link: 36808143

Variant Present in the following documents:

• 42003_2023_4519_MOESM3_ESM.xlsx, sheet 3

View BVdb publication page

---

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Nature Communications

Harding, James J JJ; Piha-Paul, Sarina A SA; Shah, Ronak H RH; Murphy, Jessica J JJ; Cleary, James M JM; Shapiro, Geoffrey I GI; Quinn, David I DI; Braña, Irene I; Moreno, Victor V; Borad, Mitesh M; Loi, Sherene S; Spanggaard, Iben I; Park, Haeseong H; Ford, James M JM; Arnedos, Mónica M; Stemmer, Salomon M SM; de la Fouchardiere, Christelle C; Fountzilas, Christos C; Zhang, Jie J; DiPrimeo, Daniel D; Savin, Casey C; Duygu Selcuklu, S S; Berger, Michael F MF; Eli, Lisa D LD; Meric-Bernstam, Funda F; Jhaveri, Komal K; Solit, David B DB; Abou-Alfa, Ghassan K GK

Publication Date: 2023-02-06

Variant appearance in text: ERBB2: S310F

PubMed Link: 36746967

Variant Present in the following documents:

• Main text
• 41467_2023_36399_MOESM3_ESM.xlsx, sheet 5
• 41467_2023_36399_MOESM1_ESM.pdf
• 41467_2023_36399_MOESM2_ESM.pdf
• 41467_2023_Article_36399.pdf

View BVdb publication page

---

Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer.

Frontiers In Immunology

Ye, Zhen Z; Zhang, Huanhuan H; Liang, Jianwei J; Yi, Shuying S; Zhan, Xianquan X

Publication Date: 2023

Variant appearance in text: ERBB2: S310F

PubMed Link: 36742322

Variant Present in the following documents:

• Table_7.xlsx, sheet 1

View BVdb publication page

---

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer.

Bmc Cancer

Harada, Yohei Y; Sato, Akemi A; Nakamura, Hideaki H; Kai, Keita K; Kitamura, Sho S; Nakamura, Tomomi T; Kurihara, Yuki Y; Ikeda, Sadakatsu S; Sueoka, Eisaburo E; Kimura, Shinya S; Sueoka-Aragane, Naoko N

Publication Date: 2023-01-23

Variant appearance in text: HER2: S310F

PubMed Link: 36690964

Variant Present in the following documents:

• Main text
• 12885_2022_Article_10428.pdf

View BVdb publication page

---

Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis.

Frontiers In Oncology

Yao, Peizhuo P; Zhang, Yinbin Y; Zhang, Shuqun S; Wei, Xinyu X; Liu, Yanbin Y; Du, Chong C; Hu, Mingyou M; Feng, Cong C; Li, Jia J; Zhao, Fang F; Li, Chaofan C; Li, Zhen Z; Du, Lisha L

Publication Date: 2022

Variant appearance in text: ERBB2: S310F

PubMed Link: 36686767

Variant Present in the following documents:

• Main text
• fonc-12-1039882.pdf

View BVdb publication page

---

Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)

Eli, Lisa D LD; Kavuri, Shyam M SM

Publication Date: 2022

Variant appearance in text: HER2: S310F

PubMed Link: 36627899

Variant Present in the following documents:

• cdr-5-4-873.pdf

View BVdb publication page

---

Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis.

Frontiers In Pharmacology

Wang, Ziyi Z; Liu, Yuxin Y; Chen, Feng F; Liao, Haiyan H; Wang, Xuesong X; Guo, Zhe Z; Wang, Zhong Z

Publication Date: 2022

Variant appearance in text: ERBB2: S310F

PubMed Link: 36605402

Variant Present in the following documents:

• Main text
• fphar-13-1079511.pdf

View BVdb publication page

---

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma.

Frontiers In Immunology

Wang, Qinyang Q; Mao, Ziyang Z; Li, Wenyuan W; Wang, Shumei S; Wang, Lei L; Chen, Lin L; Yang, Zhe Z; Fu, Xiaolan X; Jiang, Panpan P; Bai, Yixue Y; Xu, Longwen L; Zhang, Shirong S; Hou, Yuzhu Y; Jia, Xiaohui X; Jiang, Lili L; Liu, Mengjie M; Zhang, Guanjun G; Jiang, Yina Y; Guo, Hui H

Publication Date: 2022

Variant appearance in text: HER2: S310F

PubMed Link: 36591290

Variant Present in the following documents:

• Main text
• fimmu-13-1042072.pdf

View BVdb publication page

---

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer.

Frontiers In Pharmacology

Singh, Desh Deepak DD; Lee, Hae-Jeung HJ; Yadav, Dharmendra Kumar DK

Publication Date: 2022

Variant appearance in text: HER2: S310F

PubMed Link: 36578543

Variant Present in the following documents:

• Main text
• fphar-13-1089066.pdf

View BVdb publication page

---

Circulating Tumor DNA-A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques.

Cancers

Wen, Xiaosha X; Pu, Huijie H; Liu, Quan Q; Guo, Zifen Z; Luo, Dixian D

Publication Date: 2022-12-07

Variant appearance in text: ERBB2: S310F

PubMed Link: 36551512

Variant Present in the following documents:

• Main text
• cancers-14-06025.pdf

View BVdb publication page

---

Multiple receptor conversions during the course of metastatic breast cancer therapy: a case report and review of the literature.

Journal Of Medical Case Reports

Chamorro, Yolcar Y; Sandoval-Leon, Ana C AC; Vogel, Charles L CL; Nguyen, Michaela T MT; Wang, Grace G

Publication Date: 2022-12-13

Variant appearance in text: HER2: S310F

PubMed Link: 36510266

Variant Present in the following documents:

• Main text
• 13256_2022_Article_3679.pdf

View BVdb publication page

---

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: ERBB2: 929C>T; S310F

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 3
• Table_2.xlsx, sheet 2

View BVdb publication page

---

Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer.

Jama Network Open

Liu, Ze-Xian ZX; Zhang, Xiao-Long XL; Zhao, Qi Q; Chen, Yungchang Y; Sheng, Hui H; He, Cai-Yun CY; Sun, Yu-Ting YT; Lai, Ming-Yu MY; Wu, Min-Qing MQ; Zuo, Zhi-Xiang ZX; Wang, Wei W; Zhou, Zhi-Wei ZW; Wang, Feng-Hua FH; Li, Yu-Hong YH; Xu, Rui-Hua RH; Qiu, Miao-Zhen MZ

Publication Date: 2022-12-01

Variant appearance in text: ERBB2: S310F

PubMed Link: 36484990

Variant Present in the following documents:

• jamanetwopen-e2245836-s002.xlsx, sheet 3

View BVdb publication page

---

Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.

Jama Network Open

Naito, Yoichi Y; Sunami, Kuniko K; Kage, Hidenori H; Komine, Keigo K; Amano, Toraji T; Imai, Mitsuho M; Koyama, Takafumi T; Ennishi, Daisuke D; Kanai, Masashi M; Kenmotsu, Hirotsugu H; Maeda, Takahiro T; Morita, Sachi S; Sakai, Daisuke D; Watanabe, Kousuke K; Shirota, Hidekazu H; Kinoshita, Ichiro I; Yoshioka, Masashiro M; Mamesaya, Nobuaki N; Ito, Mamoru M; Kohsaka, Shinji S; Saigusa, Yusuke Y; Yamamoto, Kouji K; Hirata, Makoto M; Tsuchihara, Katsuya K; Yoshino, Takayuki T

Publication Date: 2022-12-01

Variant appearance in text: ERBB2: 929C>T

PubMed Link: 36469316

Variant Present in the following documents:

• Main text
• jamanetwopen-e2245081-s001.pdf

View BVdb publication page

---

Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.

Thoracic Cancer

Zhang, Shirong S; Wang, Wenxian W; Xu, Chunwei C; Zhang, Yongchang Y; Cai, Xiuyu X; Wang, Qian Q; Song, Zhengbo Z; Li, Ziming Z; Yu, Jinpu J; Zhong, Wenzhao W; Wang, Zhijie Z; Liu, Jingjing J; Liu, Anwen A; Li, Wen W; Zhan, Ping P; Liu, Hongbing H; Lv, Tangfeng T; Miao, Liyun L; Min, Lingfeng L; Lin, Gen G; Huang, Long L; Yuan, Jingping J; Jiang, Zhansheng Z; Pu, Xingxiang X; Rao, Chuangzhou C; Lv, Dongqing D; Yu, Zongyang Z; Li, Xiaoyan X; Tang, Chuanhao C; Zhou, Chengzhi C; Zhang, Junping J; Guo, Hui H; Chu, Qian Q; Meng, Rui R; Liu, Xuewen X; Wu, Jingxun J; Zhou, Jin J; Zhu, Zhengfei Z; Pan, Weiwei W; Dong, Xiaowei X; Pang, Fei F; Wang, Kai K; Yao, Chao C; Lin, Guomin G; Li, Site S; Yang, Zhi Z; Luo, Jiancheng J; Jia, Hongtao H; Nie, Xiuqing X; Wang, Liping L; Zhu, Youcai Y; Hu, Xiao X; Xie, Yanru Y; Lin, Xinqing X; Cai, Jing J; Xia, Yang Y; Feng, Huijing H; Wang, Lin L; Du, Yingying Y; Yao, Wang W; Shi, Xuefei X; Niu, Xiaomin X; Yuan, Dongmei D; Yao, Yanwen Y; Kang, Jing J; Zhang, Jiatao J; Zhang, Chao C; Gao, Wenbin W; Huang, Jianhui J; Zhang, Yinbin Y; Sun, Pingli P; Wang, Hong H; Ye, Mingxiang M; Wang, Dong D; Wang, Zhaofeng Z; Wan, Bing B; Lv, Donglai D; Yu, Genhua G; Shi, Lin L; Xia, Yuanli Y; Gao, Feng F; Zhang, Xiaochen X; Xu, Tao T; Zhou, Wei W; Wang, Haixia H; Liu, Zhefeng Z; Yang, Nong N; Wu, Lin L; Wang, Qiming Q; Wang, Guansong G; Hong, Zhuan Z; Wang, Jiandong J; Fang, Meiyu M; Fang, Yong Y; Zhang, Yiping Y; Song, Yong Y; Ma, Shenglin S; Fang, Wenfeng W; Lu, Yuanzhi Y

Publication Date: 2022-11-28

Variant appearance in text: HER2: S310F

PubMed Link: 36444143

Variant Present in the following documents:

• Main text
• TCA-14-91.pdf

View BVdb publication page

---

Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making.

Frontiers In Oncology

Sun, Daqiang D; Xu, Meilin M; Pan, Chaohu C; Tang, Hongzhen H; Wang, Peng P; Wu, Dongfang D; Luo, Haitao H

Publication Date: 2022

Variant appearance in text: ERBB2: 929C>T; Ser310Phe

PubMed Link: 36425562

Variant Present in the following documents:

• Table_5.xlsx, sheet 1
• Table_4.xlsx, sheet 1
• Table_3.xlsx, sheet 1

View BVdb publication page

---

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing.

Cancer Research And Treatment

Ahn, Beung-Chul BC; Han, Ye-Jeong YJ; Kim, Hye Ryun HR; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM

Publication Date: 2022-11-09

Variant appearance in text: HER2: S310F

PubMed Link: 36397236

Variant Present in the following documents:

• Main text
• crt-2022-359.pdf

View BVdb publication page

---

Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications

Boström, Martin M; Larsson, Erik E

Publication Date: 2022-11-17

Variant appearance in text: ERBB2: S310F

PubMed Link: 36396655

Variant Present in the following documents:

• 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

---

Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer.

Frontiers In Immunology

Xu, Lin L; Shi, Meiqi M; Wang, Siwei S; Li, Ming M; Yin, Wenda W; Zhang, Jingyuan J; Zhu, Jun J; Jiang, Feng F; Xia, Wenjia W; Qiu, Ninglei N; Zhang, Zhi Z; Huang, Jianfeng J; Ma, Zhifei Z; Meng, Fanchen F; Zhu, Hongyu H; Dong, Guozhang G; Wang, Jie J; Yin, Rong R

Publication Date: 2022

Variant appearance in text: rs1057519816

PubMed Link: 36389707

Variant Present in the following documents:

• DataSheet_1.xlsx, sheet 2

View BVdb publication page

---

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

Npj Precision Oncology

de Bitter, Tessa J J TJJ; de Reuver, Philip R PR; de Savornin Lohman, Elise A J EAJ; Kroeze, Leonie I LI; Vink-Börger, Marianne E ME; van Vliet, Shannon S; Simmer, Femke F; von Rhein, Daniel D; Jansen, Erik A M EAM; Verheij, Joanne J; van Herpen, Carla M L CML; Nagtegaal, Iris D ID; Ligtenberg, Marjolijn J L MJL; van der Post, Rachel S RS

Publication Date: 2022-11-05

Variant appearance in text: ERBB2: 929C>T; Ser310Phe

PubMed Link: 36335173

Variant Present in the following documents:

• 41698_2022_327_MOESM2_ESM.xlsx, sheet 3

View BVdb publication page

---

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics

Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q

Publication Date: 2022-11-04

Variant appearance in text: ERBB2: 929C>T; S310F

PubMed Link: 36333792

Variant Present in the following documents:

• 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

---

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches.

Journal Of Personalized Medicine

Bontoux, Christophe C; Benzaquen, Jonathan J; Hofman, Véronique V; Heeke, Simon S; Hannetel, Paul P; Capela-Brosseau-Laborde, Pierre P; Marquette, Charles-Hugo CH; Ilié, Marius M; Hofman, Paul P

Publication Date: 2022-10-04

Variant appearance in text: HER2: S310F

PubMed Link: 36294789

Variant Present in the following documents:

• Main text
• jpm-12-01651.pdf

View BVdb publication page

---